Persisting challenges in the early detection of hepatocellular carcinoma Ashwini Arvind, Kennedy Redmon, Amit G Singal Expert Review of Anticancer Therapy.2025; 25(3): 229. CrossRef
Exosomal FOSL1 From Cancer-associated Fibroblasts Drives the Progression and Pro-tumorigenic M2 Macrophage Polarization of Hepatocellular Carcinoma By Activating PLAU Transcription Kai Bai, Ruopeng Liang, Jian Li, Kun Zhao Applied Biochemistry and Biotechnology.2026; 198(2): 822. CrossRef
Development of an UPLC-MS/MS method for quantification of donafenib and its metabolite in rat plasma: application to drug–drug interaction Yuxin Shen, Ruibin Li, Lu Cao, Jun Wu, Haoxin Fu, Peiqi Wang, Ren-ai Xu, Ling Ji Biochemical Pharmacology.2026; 246: 117540. CrossRef
Comparison of repeat hepatectomy with radiofrequency ablation for the survival of hepatocellular carcinoma with solitary intrahepatic recurrence after hepatectomy Jialu Fu, Jiafeng Chen, Lei Jin, Junfeng Huang, Shengwei Mao, Xuhui Zhao, Weifeng Qu, Rui Yang, Yi Wang, Yichao Bu, Zhiqi Guan, Jun Gao, Xiaoling Wu, Qianfu Zhao, Tianhao Chu, Guiqi Zhu, Yuan Fang, Yinghong Shi, Weiren Liu Clinics and Research in Hepatology and Gastroenterology.2026; 50(2): 102750. CrossRef
Management and outcomes of patients with liver cancer in China and the United States Mengyuan Xu, Qiushuo Geng, Tianhao Shan, Manqi Liu, Jianguo Chen, Meicen Liu, Bingfeng Han, Changfa Xia, Xianhui Ran, Kexin Sun, Shaoming Wang, Yubing Shen, Ru Chen, Li Li, Hong Zhao, Wanqing Chen, Lingeng Lu, Yefan Zhang, Hongmei Zeng Chinese Medical Journal.2026; 139(10): 1502. CrossRef
TRIM13 Suppressed the Proliferation and Migration of Hepatocellular Carcinoma Cells by Inducing Autophagy Longxu Jiang, Danghui Lu, Kristian Holgersson, Shan Zhang, Guangyan Shi, Laszlo Szekely, Xue Bai, Yuanpeng Zhai, Xinju Chen, Takahiro Seki, Kun Li Journal of Biochemical and Molecular Toxicology.2026;[Epub] CrossRef
Research on Anti-tumor Pharmacodynamics of Multi-functional Magnetic Lipid Polymer with Specific Targeted Transmission of siRNA and its Toxicity Evaluation Yaru Liu, Chang Wang, Jie Jin, Jishan Quan, Guangyu Jin Current Pharmaceutical Design.2026; 32(19): 1524. CrossRef
Association Between Multi‐Laboratory Parameters Pre‐ and Post‐Treatment and Pathological Features and Their Values in Clinical Decision in Primary Hepatic Carcinoma Xiaowei Chi, Weifang Liu, Zihan Liu, Jie Liu Journal of Clinical Laboratory Analysis.2026;[Epub] CrossRef
ENPP2 Dysregulation Defines a Candidate Biomarker Axis Coupling Tumor‐Intrinsic cAMP Signaling to Macrophage Polarization in Hepatocellular Carcinoma Shiyi Chen, Jinli Zheng, Jianwu Long, Peng Ou, Jian Tong, Fan Lin, Shaoqiu Chen Human Mutation.2026;[Epub] CrossRef
SF3B4 stabilizes SREBF1 via 3′UTR binding to drive hepatocellular carcinoma progression Yuan Fang, Dan Wang, Lei Han, Mengge Li, Qiuyue He, WangGan Xu, HaiJing Li, Zhong Zeng, Jie Lin, HanFei Huang Frontiers in Oncology.2026;[Epub] CrossRef
Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma Biyan Gong, Dunfu Cao, Shidong Hu, Xiangyi Zhou, Leida Zhang, Fengsheng Dai, Jianheng Peng Frontiers in Immunology.2026;[Epub] CrossRef
Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma Weibin Zhang, Jia Dong, Yunfei Wu, Xiangnan Liang, Lida Suo, Liming Wang Biochemical Genetics.2025; 63(3): 2650. CrossRef
Exploring the association between air pollution and the incidence of liver cancers Xin Wu, Xin Zhang, Xiaopeng Yu, Hongyuan Liang, Shaoshan Tang, Yao Wang Ecotoxicology and Environmental Safety.2025; 290: 117437. CrossRef
α-Fetoprotein model versus Milan criteria in predicting outcomes after hepatic resection for hepatocellular carcinoma: multicentre study Chao Li, Yong-Kang Diao, Yi-Fan Li, Shao-Dong Lv, Xian-Ming Wang, Xue-Dong Wang, Qi-Xuan Zheng, Hong Wang, Han Liu, Kong-Ying Lin, Ying-Jian Liang, Ya-Hao Zhou, Wei-Min Gu, Ming-Da Wang, Lan-Qing Yao, Xin-Fei Xu, Jia-Hao Xu, Li-Hui Gu, Timothy M Pawlik, F BJS Open.2025;[Epub] CrossRef
METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery Xie Weng, Yangyue Huang, Zhuoya Fu, Xingli Liu, Fuli Xie, Jiale Wang, Qiaohua Zhu, Dayong Zheng Frontiers in Immunology.2025;[Epub] CrossRef
MSNs-loaded HMME and Erastin-mediated ferroptosis combined with sonodynamic therapy for HCC treatment Chang Zhao, Guchun Qin, Caixia Ling, Yang Zhao, Yunxi Huang, Zelong Jiang, Niqiang Zhou, Junjie Liu, Danke Su, Jinghang Jiang Journal of Cancer Research and Therapeutics.2025; 21(2): 465. CrossRef
SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming Xin Jin, Xigan He, Runze Huang, Qinyu Liu, Lei Wang, Xuanci Bai, Yibin Wu, Yixiu Wang, Ziting Jiang, Yi Shi, Gautam Sethi, Lu Wang, Weiping Zhu Journal of Experimental & Clinical Cancer Research.2025;[Epub] CrossRef
Preoperative ASAP score predicts recurrence and survival following curative hepatic resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter cohort study Dongxu Yin, Zixuan Wang, Chao Li, Huixuan Fan, Zichao Tu, Yongkang Diao, Zijie Tang, Yongyi Zeng, Han Wu, Lihui Gu, Lanqing Yao, Xinfei Xu, Feng Shen, Mingda Wang, Tian Yang European Journal of Surgical Oncology.2025; 51(10): 110361. CrossRef
Artificial intelligence for enhancing decision-making in multidisciplinary tumor boards for HCC in China Dong Li, Haoyu Wang, Fei Gao, Xifeng Fu, Junfeng Han Hepatoma Research.2025;[Epub] CrossRef
Predictive indicators of immune therapy efficacy in hepatocellular carcinoma based on neutrophil-to-lymphocyte ratio Shengzhe Lin, Yang Wang, Xinran Cai, Yunbin Ye, Yanling Chen International Immunopharmacology.2024; 128: 111477. CrossRef
Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma Ming-Da Wang, Yong-Kang Diao, Lan-Qing Yao, Zhong-Qi Fan, Ke-Chun Wang, Han Wu, Li-Hui Gu, Jia-Hao Xu, Chao Li, Guo-Yue Lv, Tian Yang iLIVER.2024; 3(1): 100083. CrossRef
Cell-Membrane-Coated Metal–Organic Framework Nanocarrier Combining Chemodynamic Therapy for the Inhibition of Hepatocellular Carcinoma Proliferation Huaying Xie, Xuhua Xiao, Xiaoyuan Yi, Kunzhao Huang, Liyan Wang Pharmaceutics.2024; 16(5): 619. CrossRef
Apolipoprotein H-based prognostic risk correlates with liver lipid metabolism disorder in patients with HBV-related hepatocellular carcinoma Yaming Liu, Zeyi Wu, Yiqun Zhao, Maochuan Zhen, Yanhong Wang, Qiusong Liu Heliyon.2024; 10(10): e31412. CrossRef
Clinical significance of LINC02532 in hepatitis B virus-associated hepatocellular carcinoma and its regulatory effect on tumor progression Wei Ding, Sujuan Xi, Kewei Gao, Danping Weng, Sheng Xu, Guoping Huang, Min Yu, Haiyan Yue, Jianguo Wang Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102403. CrossRef
Even though the combined use of ultrasound (US) and alpha-fetoprotein (AFP) is recommended for the surveillance of hepatocellular carcinoma (HCC), the utilization of AFP has its challenges, including accuracy dependent on its cut-off levels, degree of liver necroinflammation, and etiology of liver disease. Though various studies have demonstrated the utility of protein induced by vitamin K absence II (PIVKA-II) in surveillance, treatment monitoring, and predicting recurrence, it is still not recommended as a routine biomarker test. A panel of 17 experts from Asia-Pacific, gathered to discuss and reach a consensus on the clinical usefulness and value of PIVKA-II for the surveillance and treatment monitoring of HCC, based on six predetermined statements. The experts agreed that PIVKA-II was valuable in the detection of HCC in AFP-negative patients, and could potentially benefit detection of early HCC in combination with AFP. PIVKA-II is clinically useful for monitoring curative and intra-arterial locoregional treatments, outcomes, and recurrence, and could potentially predict microvascular invasion risk and facilitate patient selection for liver transplant. However, combining PIVKA-II with US and AFP for HCC surveillance, including small HCC, still requires more evidence, whilst its role in detecting AFP-negative HCC will potentially increase as more patients are treated for hepatitis-related HCC. PIVKA-II in combination with AFP and US has a clinical role in the Asia-Pacific region for surveillance. However, implementation of PIVKA-II in the region will have some challenges, such as requiring standardization of cut-off values, its cost-effectiveness and improving awareness among healthcare providers.
Citations
Citations to this article as recorded by
Global, regional, and national burden of liver cancer due to hepatitis B, 1990–2021 and projections to 2051: a systematic analysis of the Global Burden of Disease Study 2021 Peipei Yang, Wenjie Huang, Yuanyuan Xu, Qiurong Li, Xinyan Shu, Jiaqian Zuo, Wenqin Ren, Yujie Huang, Yuhao Teng, Peng Shu European Journal of Gastroenterology & Hepatology.2026; 38(2): 178. CrossRef
Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage: Correspondence to editorial on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study” Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming-Lung Yu Clinical and Molecular Hepatology.2026; 32(1): e68. CrossRef
Digital pathology-based prognostic model for hepatocellular carcinoma: Integrating pathomics signatures with clinical parameters for recurrence prediction and biological interpretation Qi Wang, Yuxi Huang, Yu Zhang, Yu Zhu, Peng Hu, Yongfu Xu, Zhen-yu Jiang, Long Liu, Shao-wei Li Computer Methods and Programs in Biomedicine.2026; 275: 109180. CrossRef
Serum Outperforms Plasma for Glypican-3 Quantification in Hepatocellular Carcinoma—A Prospective Comparative Study Ming-Tze Yang, Jiunn-Min Wang, Chen-Shiou Wu, Shou-Wu Lee, Hsin-Ju Tsai, Chia-Chang Chen, Ying-Cheng Lin, Hui-Fen Liu, Teng-Yu Lee Journal of Clinical Medicine.2026; 15(2): 448. CrossRef
Integrated spatial and single-cell transcriptomics reveals RPL8 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma Jinna Tan, Junzhu Liang, Yaoyang Li, Jiaqian He, Hui Yin, Hemeng Wu, Yuzhen Luo, Mingfen Li, Fuli Long, Hongsheng Lin Translational Oncology.2026; 64: 102663. CrossRef
Risk Scores for Stratifying Hepatocellular Carcinoma and Optimizing Surveillance Strategies Yu-Ping Chang, Yun-Chu Chen, Chen-Hua Liu Cancers.2026; 18(1): 158. CrossRef
Diagnostic Performance Comparison of AFP, PIVKA-II, GALAD Model, and ASAP Model Across Two Chemiluminescence Immunoassay Platforms for Hepatocellular Carcinoma Yuan Huang, Rui Ding, Yue Cui, Peng Li, Jie Niu, Guan-Hua Wang, Xu-Zhen Qin Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Development and validation of the APTNM staging system: Integration of serum biomarkers with TNM classification for enhanced prognostic stratification following hepatectomy for hepatocellular carcinoma Xin Li, Yi-Fei Liu, Chen-Yao Zhou, Jun Lu, Guo-Wei Wang, Zi-Jie Tang, Zi-Chao Tu, Yong-Yi Zeng, Wei Guo, Ji-Li Li, Jia-Hao Xu, Chao Li, Ming-Da Wang, Feng Shen, Fei Wu, Tian Yang European Journal of Surgical Oncology.2026; 52(2): 111384. CrossRef
Artificial Intelligence Applications in the Diagnosis, Treatment, and Prognosis of Hepatocellular Carcinoma Ming-Ying Lu, Jacky Chung-Hao Wu, Henry Horng-Shing Lu, Mohammed Eslam, Ming-Lung Yu Gut and Liver.2026; 20(1): 5. CrossRef
Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patients Alberto Izquierdo-Martínez, Ángela Rojas, Ricardo Rubio-Sánchez, Inmaculada Dominguez-Pascual, Manuel Romero-Gómez, Daniel Fatela-Cantillo Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.2026; 7(1): 43. CrossRef
68Ga-FAPI-04 PET/CT in the Diagnosis of Hepatocellular Carcinoma Associated with Cirrhosis: Diagnostic Value, Correlation Between PET Parameters of the Tumor and Its Size, and PIVKA-II Levels Zhamilya Zholdybay, Zhanar Zhakenova, Bekzhan Issamatov, Madina Gabdullina, Yevgeniya Filippenko, Suriya Yessentayeva, Galymzhan Alisherov, Jandos Amankulov, Ildar Fakhradiyev Diagnostics.2026; 16(2): 249. CrossRef
Development and validation of six-parameter laboratory-based prognostic model (APHPBA score) for patients undergoing hepatectomy for hepatitis B virus-related hepatocellular carcinoma Yi-Fei Liu, Hong Wang, Ya-Hao Zhou, Xin Li, Zu-Chao Du, Zi-Jie Tang, Wen-Long Zhai, Yong-Yi Zeng, Ting-Hao Chen, Yong-Kang Diao, Zi-Chao Tu, Li-Hui Gu, Han Wu, Feng Shen, Ming-Da Wang, Lai Wang, Fei Wu, Tian Yang HPB.2026; 28(5): 635. CrossRef
Diagnosis and Treatment Report of a Case of Small Hepatocellular Carcinoma With Left Adrenal Metastasis and Hemorrhage in an Elderly Male Hepatitis B Virus Carrier Guanyu Zhou, Fan Wu, Tianhe Feng, Tianqi Lin Clinical Case Reports.2026;[Epub] CrossRef
Gamma-Glutamyl Transferase Improves Biological Risk Stratification in Living Donor Liver Transplantation for Hepatocellular Carcinoma Abu Bakar Hafeez Bhatti, Muhammad Usman Shafique, Muhammad Nauman Ul Haq, Hajira Ghairat, Jamshaid Anwar, Zafar Ali Journal of Gastrointestinal Cancer.2026;[Epub] CrossRef
Serum Raman spectroscopy combined with PCA-CNN model for the diagnosis of hepatitis B, liver cirrhosis, and Hepatocellular Carcinoma Baiyun Wang, Liang Zhang, Guohua Wu, Longfei Yin, Xuewen Long, Ting Mei, Yishu Tang Vibrational Spectroscopy.2026; 143: 103896. CrossRef
The prognostic significance and clinical application of Mac-2 binding protein glycosylation Isomer, Lectin-Reactive α-Fetoprotein Fraction, and protein induced by vitamin K Absence-II in resectable hepatocellular carcinoma Yoriko Nomura, Norifumi Harimoto, Kazuaki Hashimoto, Kazuki Takeishi Surgery Today.2026; 56(7): 1369. CrossRef
Deciphering the contribution of 5’-tiRNA- Lys-CTT as an emerging early diagnostic biomarker for hepatocellular carcinoma Abinash Nayak Discover Oncology.2026;[Epub] CrossRef
Prediction of Tumor Progression After Microwave Ablation of Hepatocellular Carcinoma by Contrast-Enhanced Ultrasound Combined with Immunohistochemical Markers Tian-Tian Dong, Ming Li, Yuan-Yuan Li, Ci Yin, Fang Nie Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Research Progress of Liquid Biopsy Technology in the Early Diagnosis of Hepatocellular Carcinoma 佳玮 李 Advances in Clinical Medicine.2026; 16(03): 271. CrossRef
AFP/PIVKA-II double-positive status indicates a high-risk subtype of hepatocellular carcinoma in liver transplantation: retrospective cohort study and phosphoproteome evaluation Chenhao Xu, Xingyu Luo, Xixi Fang, Ze Xiang, Renyi Su, Wenzhi Shu, Zhisheng Zhou, Yisu Song, Zhengyang Lu, Shusen Zheng, Xiao Xu, Xuyong Wei, Zhe Yang International Journal of Surgery.2026; 112(3): 7373. CrossRef
Optimizing the Evaluation of Biomarkers for Hepatocellular Carcinoma Surveillance Haiyan Yang, Siru Zhao, Rong Fan Gastroenterology.2026;[Epub] CrossRef
Hepatocellular Carcinoma Over Three Decades: from Screening Evolution to Integrated Therapeutic Strategies Ke Huang, Myoung Ok Kim Journal of Cancer Prevention.2026; 31(2): 54. CrossRef
Protein induced by vitamin K absence or antagonist-II in hepatocellular carcinoma with normal alpha-fetoprotein: Current advances and controversies Xi-Ming Wang, Hui-Gang Li, Jin-Xin Xu, Xiang Wu, Hong Li World Journal of Gastrointestinal Oncology.2026;[Epub] CrossRef
Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis Qi Zhang, Zhenwu Lei, Hezi Qing, Xingwu Xie Frontiers in Immunology.2026;[Epub] CrossRef
The Critical Role of GALNTs‐Regulated O‐GalNAc Glycosylation in Cancer Malignancy Jiahao Liu, Sihan Wu, Ge Zhang, Jiehan Li, Yuhan Yin, Aman Uiiah, Sanfei Peng, Yang Fu The FASEB Journal.2026;[Epub] CrossRef
Integrated serum proteomics and metabolomics reveal an INR-associated multi-omics signature in hepatocellular carcinoma Yuying Cai, Lingna Lyu, Jiayi Ma, Xiaoru Wang, Wenxia Ma, Jiming Yin, Shanshan Wang Clinical Proteomics.2026;[Epub] CrossRef
Application of Health Examination in Early Screening of Tumors Bing Han, Ruixue Wang Seminars in Ultrasound, CT and MRI.2026;[Epub] CrossRef
The Use of Non‐Contrast Abbreviated MRI for the Detection of Recurrent Hepatocellular Carcinoma in Postoperative Surveillance Jianwei Chen, Yuemin Zhu, Dechun Zheng, Liting Wen, Juyi Wu, Qiuyuan Yue, Zhuting Fang Journal of Magnetic Resonance Imaging.2026;[Epub] CrossRef
Prognostic value of serum aldo-keto reductase family 1 member B10 in hepatocellular carcinoma Yun-Ling Du, Chang-Jiang Shi, Fang-Yuan Gao, Shou-Jun Xie, Meng-Na Zhang, Zhu-Qing Zhang, Wei Qiu, Ying Ming World Journal of Gastrointestinal Surgery.2026;[Epub] CrossRef
Prognostic value of PIVKA-II and routine perioperative laboratory indices for recurrence prediction after curative resection of hepatocellular carcinoma Yangyu Mo, Yaxian Wu, Miantao Wu, Yingchun Zhou Clinica Chimica Acta.2026; 591: 121174. CrossRef
Evaluation of metabolite biomarker candidates in detecting HCC in patients with liver cirrhosis Md Mamunur Rashid, Rency S. Varghese, Muhammad Salman Sajid, Zaki A. Sherif, Alexander Kroemer, Habtom W. Ressom Metabolomics.2026;[Epub] CrossRef
tRF-34-P4R8YP9LON4VHM may serve as a promising potential diagnostic biomarker for hepatocellular carcinoma Yuchen Guo, Minjie Huang, Yuyuan Lu, Tianxin Xu, Xinqi Ge, Yan Huang, Wei Zong, Kan Ni Scientific Reports.2026;[Epub] CrossRef
CRAPT-M: An effective prognostic predictor for hepatocellular carcinoma patients treated with locoregional-bevacizumab-immunotherapy Ze-Hao Zheng, Rui Xiao, Na Liu, Ben-Yi He, Wei Yu, Zhong-Shi Wu, Min-Shan Chen, Jie Mei, Dan-Dan Hu, Rong-Ping Guo World Journal of Gastroenterology.2026;[Epub] CrossRef
APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update Hong You, Rakhi Maiwall, Jing Chen, Sang Hoon Ahn, Kadir Dokmeci, Xiaoguang Dou, Manal El-Sayed, Jian-Gao Fan, Rino Gani, Zhiliang Gao, Jacob George, Hasmik Ghazinian, George Goh, Saeed Hamid, Jinlin Hou, Shang-Chin Huang, Dong Ji, Jidong Jia, Tatsuo Kand Hepatology International.2026;[Epub] CrossRef
Surveillance for Hepatocellular Carcinoma in Cirrhosis: End of Monopoly for Serum Alpha Fetoprotein Lung-Yi Mak, Man-Fung Yuen Gastroenterology.2025; 168(2): 217. CrossRef
Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies Jinlin Hou, Thomas Berg, Arndt Vogel, Teerha Piratvisuth, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Katarina Malinowsky, Peter Findeisen, Johannes Kolja Hegel, Wenzel Schöning, Kairat Madin, Konstantin Kroeniger, Henry Lik-Yuen Chan, Ashish Sharma JHEP Reports.2025; 7(2): 101263. CrossRef
Establishment of sex-specific reference intervals for PIVKA-II in Southwest China: A real-world data analysis Bin Wei, Yalin Zheng, Lixin Li, Limei Luo, Ying Guo Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2025; 62(3): 202. CrossRef
Comparative Validation of Prediction Models for HCC Outcomes in Living Donor Liver Transplantation: Superiority of Tumor Markers to Imaging Study Hwa‐Hee Koh, Minyu Kang, Deok‐Gie Kim, Jae Hyon Park, Eun‐Ki Min, Jae Geun Lee, Myoung Soo Kim, Dong Jin Joo Journal of Gastroenterology and Hepatology.2025; 40(3): 626. CrossRef
Rapid evaluation of hepatocellular carcinoma by detecting plasma exosomes with time-resolved fluorescence immunochromatographic test strips Jiaming Li, Jianfen Su, Minghui Li, Yaofen Wu, Huiqiang Chen, Xihua Fu, Hongliang Yao, Jinping Chen, Yuntao Liu, Jie Zan Microchimica Acta.2025;[Epub] CrossRef
Prognostic Value of the ASAP Score for Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multicenter Analysis of 1,239 Patients Tian Yang, Dong-Xu Yin, Yong-Kang Diao, Ming-Da Wang, Xian-Ming Wang, Yong-Yi Zeng, Zhong Chen, Han Liu, Fu-Jie Chen, Yu-Chen Li, Jia-Hao Xu, Han Wu, Lan-Qing Yao, Xin-Fei Xu, Chao Li, Li-Hui Gu, Alfred W. Chieh Kow, Timothy M. Pawlik, Feng Shen Journal of Clinical and Experimental Hepatology.2025; 15(3): 102497. CrossRef
Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target Chao Xu, Litao Liang, Guoqing Liu, Yanzhi Feng, Bin Xu, Deming Zhu, Wenbo Jia, Jinyi Wang, Wenhu Zhao, Xiangyu Ling, Yongping Zhou, Wenzhou Ding, Lianbao Kong Cancer Cell International.2025;[Epub] CrossRef
Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study Yoshitaka Saegusa, Yuki Imaoka, Masahiro Ohira, Tsuyoshi Kobayashi, Naruhiko Honmyo, Michinori Hamaoka, Takashi Onoe, Daisuke Takei, Koichi Oishi, Tomoyuki Abe, Toshihiro Nakayama, Miho Akabane, Kazunari Sasaki, Hideki Ohdan Journal of Gastrointestinal Surgery.2025; 29(4): 101980. CrossRef
3D synergistic tumor-liver analysis further improves the efficacy prediction in hepatocellular carcinoma: a multi-center study Yurong Jiang, Jiawei Zhang, Zhaochen Liu, Jinxiong Zhang, Xiangrong Yu, Danyan Lin, Dandan Dong, Mingyue Cai, Chongyang Duan, Shuyi Liu, Wenhui Wang, Yuan Chen, Qiyang Li, Weiguo Xu, Meiyan Huang, Sirui Fu BMC Cancer.2025;[Epub] CrossRef
Teaching design for chapter “primary liver cancer” in surgery course based on the clinical theory and clerkship synchronization model in the era of New Medicine Feng Ye, Qiang Cai, Xiaoyong Gong, Jiajun Ren, Ruixin Sun, Chang Liu, Xiaoli Wang, Yuan Qiao Global Medical Education.2025; 2(1): 149. CrossRef
Development and validation of a new prognostic tool for hepatocellular carcinoma undergoing resection: The Weighted Alpha-Fetoprotein Tumor Burden Score (WATS) Tonghui Lu, Kailing Xie, Yan Chen, Mingxiu Ma, Yaming Guo, Tianqiang Jin, Chaoliu Dai, Feng Xu European Journal of Surgical Oncology.2025; 51(6): 109677. CrossRef
Divergent trends in cirrhosis and liver cancer highlight the ongoing efforts required for hepatitis elimination Grace Lai-Hung Wong, Henry Lik-Yuen Chan Hepatology.2025; 82(5): 1056. CrossRef
CA19-9, CEA and PIVKA-Ⅱ as a novel panel of serum markers for diagnosis of pancreatic cancer Meifang Wang, Hongying Bu, Weijia Luo, Xi Zeng, Guodong Chen, Yingchun He, Deliang Cao Clinical Biochemistry.2025; 137: 110902. CrossRef
Tumor burden score combined with AFP and PIVKA-II (TAP score) to predict the prognosis of hepatocellular carcinoma patients after radical liver resection Zhan-Cheng Qiu, You-Wei Wu, Jun-Long Dai, Wei-Li Qi, Chu-Wen Chen, Yue-Qing Xu, Jun-Yi Shen, Chuan Li, Tian-Fu Wen Langenbeck's Archives of Surgery.2025;[Epub] CrossRef
The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer Yue Liu, Wenrong Jiang, Xiangxiao Li, Hu Zhao, Shiwen Wang Journal of Hepatocellular Carcinoma.2025; Volume 12: 513. CrossRef
5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation Danjun Song, Zhou Zhang, Jiaping Zheng, Wei Zhang, Jiabin Cai Biomarker Research.2025;[Epub] CrossRef
Des-γ-carboxy Prothrombin in hepatocellular carcinoma post-operative recurrence risk evaluation Xinting Pan, Yang Zhou, Zhenli Li, Pengfei Guo, Jianyang Zeng, Xiuqing Dong, En Hu, Liman Qiu, Zhixiong Cai, Geng Chen, Xiaolong Liu Communications Medicine.2025;[Epub] CrossRef
Assessing the Validity of the AASLD Surgical Treatment Algorithm in Patients with Early-Stage Hepatocellular Carcinoma Aryoung Kim, Byeong Geun Song, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Myung Ji Goh, Dong Hyun Sinn Gut and Liver.2025; 19(2): 265. CrossRef
Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation Meng Sha, Jun Wang, Jie Cao, Zhi-Hui Zou, Xiao-ye Qu, Zhi-feng Xi, Chuan Shen, Ying Tong, Jian-jun Zhang, Seogsong Jeong, Qiang Xia Clinical and Molecular Hepatology.2025; 31(Suppl): S285. CrossRef
Key prognostic factors in transarterial chemoembolization combined with sorafenib treatment for hepatocellular carcinoma with portal vein tumor thrombosis Zilun Lei American Journal of Cancer Research.2025; 15(2): 517. CrossRef
Cost‐Effective Identification of Hepatocellular Carcinoma from Cirrhosis or Chronic Hepatitis Virus Infection Using Eight Methylated Plasma DNA Markers Tian Yang, Mingda Wang, Nanya Wang, Mingxin Pan, Yu Xu, Qiancheng You, Lanqing Yao, Jiahao Xu, Lihui Gu, Xiaodong Sun, Lei Zhang, Jiayue Xu, Bingsi Li, Guoqiang Wang, Shangli Cai, Guoyue Lv, Feng Shen Advanced Science.2025;[Epub] CrossRef
Paracancerous binuclear hepatocytes assessed by computer program is a novel biomarker for short term recurrence of hepatocellular carcinoma after surgery Yifan Zhang, Yiquan Lu, Nan Wang, Fengjie Hao, Yongjun Chen, Xiaochun Fei, Junqing Wang Scientific Reports.2025;[Epub] CrossRef
Preoperative identification of hepatocellular carcinoma from focal liver lesions ≤ 20 mm in high-risk patients using clinical and contrast-enhanced ultrasound features Xin-Yuan Hu, Yi-Kang Sun, Yao Miao, Xiao-Ling Chen, Dan Lu, Bo-Yang Zhou, Li-Fan Wang, Chong-Ke Zhao, Hao-Hao Yin, Xiao-Long Li, Zi-Tong Chen, Ya-Qin Zhang, Ming-Rui Zhu, Xin Guan, Er-Xuan Wu, Hong Han, Li-Ping Sun, Qing Lu, Hui-Xiong Xu European Journal of Radiology.2025; 187: 112076. CrossRef
Plasma methylated HIST1H3G as a non-invasive biomarker for diagnostic modeling of hepatocellular carcinoma Weiwei Zhu, Huifen Wang, Yudie Cai, Jun Lei, Jia Yu, Ang Li, Zujiang Yu Frontiers in Medicine.2025;[Epub] CrossRef
Postoperative regular follow-up in hepatocellular carcinoma: Transforming early detection into survival gains Alfred Wei Chieh Kow Hepatobiliary & Pancreatic Diseases International.2025; 24(3): 237. CrossRef
New insights into biomarkers and risk stratification to predict hepatocellular cancer Katrina Li, Brandon Mathew, Ethan Saldanha, Puja Ghosh, Adrian R. Krainer, Srinivasan Dasarathy, Hai Huang, Xiyan Xiang, Lopa Mishra Molecular Medicine.2025;[Epub] CrossRef
The immune-reinforcements of Lenvatinib plus anti-PD-1 and their rationale to unite with TACE for unresectable hepatocellular carcinoma treatment Jiayun Jiang, Hui Zhang, Yanjiao Ou, Jiejuan Lai, Yulan Huang, Wenyun Cai, Chong Li, Leida Zhang, Yu Fu Immunology Letters.2025; 275: 107003. CrossRef
HES V2.0 surpasses GALAD for HCC detection: a review of multi-dimensional biomarker scores and studies Fouad Jaber, Hashem B. El-Serag Hepatic Oncology.2025;[Epub] CrossRef
Integrated spatial and single cell transcriptomics identifies PRKDC as a dual prognostic biomarker and therapeutic target in hepatocellular carcinoma Wenpeng Pang, Yunyong Wang, Xiaohang Lu, Minpeng Li, Fuli Long, Songlin Chen, Yuan Yu, Mingfen Li, Hongsheng Lin Scientific Reports.2025;[Epub] CrossRef
Hepatocellular Carcinoma: The Search for an Optimal Screening Test Sara Haj Ali, Shahd I Alqato, Amjad M Almansi, Noor S Haj Ali, Mohammad A Amaireh Middle East Journal of Digestive Diseases.2025; 17(1): 31. CrossRef
Invited commentary on “Tumor biology characteristics score based on alpha-fetoprotein and prothrombin induced by vitamin K absence-II predicts recurrence and survival after curative resection for hepatocellular carcinoma: a multicenter cohort study” Abu Bakar Hafeez Bhatti Journal of Gastrointestinal Surgery.2025; 29(7): 102076. CrossRef
Development of a chitosanase 3-like protein 1 assay kit and study of its application in patients with hepatocellular carcinoma Min Liu, Yanru Qiu, Erfu Xie, Pu Qian, Shuxian Yang, Simin Zhao, Wenjun Yan, Xuan Huang, Shuang Han BMC Biotechnology.2025;[Epub] CrossRef
Predictability of clinical outcomes after external beam radiotherapy for hepatocellular carcinoma according to tumor marker dynamics Sunmin Park, Chai Hong Rim, Young Kul Jung, Hyung Joon Yim, Hwan Hoon Chung, Won Sup Yoon, Gregory Tiao PLOS One.2025; 20(5): e0323450. CrossRef
Tumor marker pseudoprogression and immune-related cholangitis during conversion therapy for massive hepatocellular carcinoma: a case report Xiaodong Zhang, Luyi Zhang, Shuangying Zhao, Lingling Dai, Huayu Li, Xudong Wu, Huanjun Yan, Rongfeng Lin, Kelei Zhu Frontiers in Immunology.2025;[Epub] CrossRef
Current and new strategies for hepatocellular carcinoma surveillance Natchaya Polpichai, Chongkonrat Maneenil, Pojsakorn Danpanichkul, Chitchai Rattananukrom, Ashok Choudhury, Yu Jun Wong, Pimsiri Sripongpun, Suthat Liangpunsakul, Apichat Kaewdech Gastroenterology Report.2025;[Epub] CrossRef
Alpha-fetoprotein: A Multifaceted Player in Cancer Biology Mete Ucdal, Yigit Yazarkan, Gamze Sonmez, Basak Celtikci, Yasemin Balaban Euroasian journal of hepato-gastroenterology.2025; 15(1): 72. CrossRef
Erratum to “Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study” [J Gastrointest Surg 29 (2025) 101980] Yoshitaka Saegusa, Yuki Imaoka, Masahiro Ohira, Tsuyoshi Kobayashi, Naruhiko Honmyo, Michinori Hamaoka, Takashi Onoe, Daisuke Takei, Koichi Oishi, Tomoyuki Abe, Toshihiro Nakayama, Miho Akabane, Kazunari Sasaki, Hideki Ohdan Journal of Gastrointestinal Surgery.2025; 29(8): 102129. CrossRef
Hepatocellular Carcinoma: Review of Indian Literature Vaishnavi Konda, Shanthi Vijayaraghavan Gastroenterology, Hepatology and Endoscopy Practice.2025; 5(3): 95. CrossRef
Long-Term Prognostic Value of AFP and PIVKA-II in HCC After Living Donor Liver Transplantation: A Single-Center Retrospective Study Saran Ochir Gongor, YoungRok Choi, Gayoung Kim, Min Kyoung Kim, Sang Hyuk Park, Jiyoung Kim, Jae-Yoon Kim, Su young Hong, Jeong-Moo Lee, Suk Kyun Hong, Kwang-Woong Lee Transplant International.2025;[Epub] CrossRef
Prothrombin-induced by vitamin K absence II as a prognostic factor in living donor liver transplantation for hepatocellular carcinoma Abu Bakar Hafeez Bhatti, Usman Shafique, Nazish Ahmed, Ghazanfar Abbas, Muslim Atiq, Haseeb Haider Zia, Nusrat Yar Khan, Atif Rana Scientific Reports.2025;[Epub] CrossRef
Evaluation of serum hsa_tsr014055 as a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma Jing Xu, Bairong Chen, Jing Qi, Jinran Wu, Wei Feng, Kangfeng Jin, Hongyi Bao, Lin Chen, Feng Wang Annals of Medicine.2025;[Epub] CrossRef
Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC Antonella Farina, Gaia Cicolani, Valentina Viggiani, Matteo Maini, Antonio Angeloni, Emanuela Anastasi International Journal of Molecular Sciences.2025; 26(15): 7581. CrossRef
Preoperative ASAP score predicts recurrence and survival following curative hepatic resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter cohort study Dongxu Yin, Zixuan Wang, Chao Li, Huixuan Fan, Zichao Tu, Yongkang Diao, Zijie Tang, Yongyi Zeng, Han Wu, Lihui Gu, Lanqing Yao, Xinfei Xu, Feng Shen, Mingda Wang, Tian Yang European Journal of Surgical Oncology.2025; 51(10): 110361. CrossRef
Sex disparity in hepatocellular carcinoma recurrence after curative liver resection: a multicenter comprehensive analysis Mu-Gen Dai, Si-Yu Liu, Qing Xu, Wen-Feng Lu, Lei Liang, Jun-Wei Liu, Kun Zhang, Bin Ye European Journal of Gastroenterology & Hepatology.2025; 37(11): 1275. CrossRef
Clinical performance of GAAD score, alpha-fetoprotein, and PIVKA-II in diagnosing hepatocellular carcinoma in the Vietnamese cohort Thuy Thi Thu Pham, Dat Tan Ho, Toan Bao Nguyen, Hai Thanh Phan Discover Oncology.2025;[Epub] CrossRef
Targeting glypican-3 as a new frontier in liver cancer therapy Chen-Shiou Wu, Teng-Yu Lee, Hsu-Wen Chao World Journal of Hepatology.2025;[Epub] CrossRef
Early PIVKA-II Response Associated with Treatment Efficacy and Survival Outcomes for Patients with Advanced Hepatocellular Carcinoma Receiving Immune Checkpoint Inhibitors and Targeted Therapy Zheng-Kang Fang, Yu-Ting Xiao, Xia Feng, Zhe-Jin Shi, Si-Yu Liu, Yang Yu, Li-Ming Jin, Dong-Sheng Huang, Cheng-Wu Zhang, Jun-Wei Liu, Lei Liang Journal of Hepatocellular Carcinoma.2025; Volume 12: 2235. CrossRef
Nanomaterial-Mediated Electrochemical and Optical Biosensors and Their Application in Tumour Marker Detection Xinlan Wang, Jingyi Hei, Tao Zhao, Xiyu Liu, Yong Huang Sensors.2025; 25(18): 5902. CrossRef
Combined Analysis of Protein Induced by Prothrombin Induced by Vitamin K Absence (PIVKA) and Alpha-L-Fucosidase (AFU) with Alpha-Fetoprotein (AFP) May Improve the Diagnostic Efficacy for Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Haisong Hou, Ruiqiang Weng, Liu Liang, Wendao Han International Journal of General Medicine.2025; Volume 18: 6031. CrossRef
Leveraging artificial intelligence to validate traditional biomarkers and drug targets in liver cancer recovery: a mini review Shengjian Wu, Xiaoqiao Chen, Yuxiu Ji, Chi Zhang, Yujie Xie, Bin Liang Frontiers in Pharmacology.2025;[Epub] CrossRef
Pilot Study of PIVKA-II in the Prognostic Assessment of Hepatocellular Carcinoma in Chronic Viral Hepatitis: Comparative Findings from HBV and HCV Cohorts from a Single Center in Serbia Ivana Milošević, Nataša Nikolić, Sanja Stanković, Ana Filipović, Jovana Ranin, Irena Paunović, Jelena Simić, Branko Beronja Biomedicines.2025; 13(11): 2653. CrossRef
Clinical Implications and Novel Insights into Adolescent Primary Liver Cancer: A Nightmare for Adolescents? Huidong Guo, Xiaojun Chen, Rong Li, Jianzhen Shen, Donghui Gan, Yue Yin, Hehui Zhang, Jiachen Xie, Longfei Xie, Yanquan Liu Journal of Hepatocellular Carcinoma.2025; Volume 12: 2513. CrossRef
MRI-based 2.5D deep learning and radiomics effectively predicted microvascular invasion and Ki-67 expression in hepatocellular carcinoma Hongmei Yu, Depeng Kong, Xiaojun Mo, Ju Huang, Jie Wu, Yang Wang, Feizhou Du, Nima Broomand Lomer, PLOS One.2025; 20(11): e0336579. CrossRef
5’-transfer RNA halve-lysine-CTT as a promising biomarker for early detection of hepatocellular carcinoma Jie Yuan, Wen-Chao Gu, Tian-Xin Xu, Xian-Juan Shen, Xian Li, Lei Shen, Yan Zhang, Shao-Qing Ju World Journal of Gastrointestinal Oncology.2025;[Epub] CrossRef
Protein Induced by Vitamin K Absence or Antagonist‐II: Significantly Elevated in Obstructive Jaundice and Sepsis Patients Without Hepatocellular Carcinoma Ke Zhang, Xiarui Ye, Xianran Fu Journal of Clinical Laboratory Analysis.2025;[Epub] CrossRef
Rapid Detection and Purification of Extracellular Vesicles for Hepatocellular Carcinoma Screening Using a Plasmonic Metasurface Integrated with the Kolmogorov–Arnold Network Jiaheng Zhu, Chenhongmei Wang, Tianhao Huang, Lihuang Zeng, Qiang Niu, Xinyue Huang, Hanyang Chen, Mengqi Jiang, Baichang Deng, Yiming Yan, Xiaohui Liu, Junjie Chen, Yinong Xie, Jiaqing Shen, Wei Chen, Yuan Gao, Kaibin Chen, Xiangyujie Lin, Lijun Zeng, Bo ACS Nano.2025; 19(49): 41557. CrossRef
Early screening for liver cancer must be performed Zi-Han Liu, Wen-Jun Wang, Shuang-Suo Dang World Journal of Hepatology.2025;[Epub] CrossRef
Adjuvant Sintilimab with or without Anti-VEGF Therapy After Resection in Hepatocellular Carcinoma with Microvascular Invasion: A Multicenter Retrospective Study Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Yi-Tao Zheng, Yun-Feng Shan, Shu-Qun Cheng Journal of Hepatocellular Carcinoma.2025; Volume 12: 2735. CrossRef
Exosomal microRNAs in Hepatocellular Carcinoma: Diagnostic and Prognostic Applications Sarang Kim, Nayeon Gu, Tae-Su Han Convergence Hepatology.2025; 1(1): 44. CrossRef
Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels Kuan-Jung Huang, Chun-Ting Ho, Pei-Chang Lee, San-Chi Chen, Chien-An Liu, Shu-Cheng Chou, I-Cheng Lee, Yi-Hsiang Huang, Jiing-Chyuan Luo, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su Journal of the Chinese Medical Association.2025; 88(12): 915. CrossRef
The predictive value of dynamic changes in neutrophil-to-lymphocyte ratio for the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization Junyu Zhou, Jiaqian Gao, Qi He, Kai Lei, Wenfeng Zhang, Yue Li Discover Oncology.2025;[Epub] CrossRef
Serum Biomarkers for Hepatocellular Carcinoma: A Comparative Review of Traditional and Emerging Markers Min Kyung Park Journal of Digestive Cancer Research.2025; 13(3): 242. CrossRef
Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein Quirino Lai, Takashi Ito, Samuele Iesari, Toru Ikegami, Daniele Nicolini, Zoe Larghi Laureiro, Massimo Rossi, Marco Vivarelli, Tomoharu Yoshizumi, Etsurou Hatano, Jan Lerut Liver Transplantation.2024; 30(5): 472. CrossRef
PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resection Zhan‐cheng Qiu, You‐wei Wu, Wei‐li Qi, Chuan Li Cancer Medicine.2024;[Epub] CrossRef
Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma Ming-Da Wang, Yong-Kang Diao, Lan-Qing Yao, Zhong-Qi Fan, Ke-Chun Wang, Han Wu, Li-Hui Gu, Jia-Hao Xu, Chao Li, Guo-Yue Lv, Tian Yang iLIVER.2024; 3(1): 100083. CrossRef
Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan Wei Teng, Hung-Wei Wang, Shi-Ming Lin Liver Cancer.2024; 13(5): 468. CrossRef
Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions Xiaoling Long, Huan Zeng, Yun Zhang, Qiulong Lu, Zhao Cao, Hong Shu Journal of Hepatocellular Carcinoma.2024; Volume 11: 607. CrossRef
Celestial Insights: Unraveling the Role of miR-3682-3p in Hepatocellular Carcinoma Pei-Dong Miao, Ying Li, Yu-Dong Jiang Clinical and Translational Gastroenterology.2024; 15(4): e00690. CrossRef
Research progress of protein induced by vitamin K absence or antagonist II in liver transplantation for hepatocellular carcinoma Zheyu Zhou, Qiaoyu Liu, Jinsong Liu, Wenwen Li, Shuya Cao, Jiawei Xu, Jun Chen, Xiaoliang Xu, Chaobo Chen Heliyon.2024; 10(9): e30622. CrossRef
Optimizing care of HBV infection and HBV-related HCC Shi Yan Lee, Benjamin Kai Yi Nah, Jazleen Leo, Jia Hong Koh, Daniel Q. Huang Clinical Liver Disease.2024;[Epub] CrossRef
Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim Clinical and Molecular Hepatology.2024; 30(3): 360. CrossRef
Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients Mingda Wang, Guojun Qian, Hongmei Xiao, Xingkai Liu, Liyang Sun, Zhong Chen, Kongying Lin, Lanqing Yao, Chao Li, Lihui Gu, Jiahao Xu, Xiaodong Sun, Wei Qiu, Timothy M Pawlik, Wan Yee Lau, Guoyue Lv, Feng Shen, Tian Yang The Oncologist.2024; 29(12): e1723. CrossRef
The ARH score, a practical guide to decision-making for retreatment with hepatic arterial infusion chemotherapy in hepatocellular carcinoma patients Jie Mei, Chengyou Yu, Feng Shi, Renguo Guan, Shaohua Li, Chong Zhong, Rongping Guo, Wei Wei International Immunopharmacology.2024; 138: 112551. CrossRef
Monocyte distribution width as a promising biomarker for differential diagnosis of chronic hepatitis, cirrhosis, and hepatocellular carcinoma Sheng Lin, Xinyao Yang, Xin Yang, Minjie Tang, Xiaobao Yao, Yuchen Ye, Qunfang Huang, Jinlan Huang, Jiejuan Li, Qiang Yi, Wennan Wu, Shiqi Li, Yaru Lei, Bin Yang, Can Liu, Qishui Ou, Zhen Xun Frontiers in Immunology.2024;[Epub] CrossRef
Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment Rosmawati Mohamed, Wendy Wang, Tawesak Tanwandee, Irsan Hasan, Cam Phuong Pham, Young-Suk Lim, Sheng-Nan Lu, Murallitharan Munisamy, Thi Thanh Huong Tran, Evy Ratnawati, Wattana Sukeepaisarnjaroen, Mahir Karababa, Chee-Kiat Tan Journal of Gastrointestinal Cancer.2024; 55(3): 1333. CrossRef
Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma Ji Yeon Lee, Pil Soo Sung Gut and Liver.2024; 18(4): 558. CrossRef
Prognosis of Patients with Hepatocellular Carcinoma Treated with TACE: A New Score Combining Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Shang-Yu Lu, Han-Yao Sun, Yan Zhou, Xi Luo, Sheng Liu, Wei-Zhong Zhou, Hai-Bin Shi, Wei Yang, Wei Tian Journal of Hepatocellular Carcinoma.2024; Volume 11: 1979. CrossRef
CEUS LI-RADS in Combination With the Serum Biomarker-Based ASAP Model Improves the Diagnostic Performance of HCC in High-Risk Patients Rong Wen, Yuting Peng, Yiqiong Liang, Yuquan Wu, Haiyuan Li, Yanxia Chen, Yan Qin, Zhiyuan Wen, Huanyu Cui, Yun He, Hong Yang Ultrasound in Medicine & Biology.2024; 50(11): 1739. CrossRef
Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma Lung-Yi Mak Journal of Liver Cancer.2024; 24(2): 145. CrossRef
Construction and evaluation of a liver cancer risk prediction model based on machine learning Ying-Ying Wang, Wan-Xia Yang, Qia-Jun Du, Zhen-Hua Liu, Ming-Hua Lu, Chong-Ge You World Journal of Gastrointestinal Oncology.2024; 16(9): 3839. CrossRef
Early identification of hepatocellular carcinoma patients at high-risk of recurrence using the ADV score: a multicenter retrospective study Shuya Cao, Zheyu Zhou, Chaobo Chen, Wenwen Li, Jinsong Liu, Jiawei Xu, Chunlong Zhao, Yihang Yuan, Zhenggang Xu, Huaiyu Wu, Guwei Ji, Xiaoliang Xu, Ke Wang World Journal of Surgical Oncology.2024;[Epub] CrossRef
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma Yau-Tuen Chan, Cheng Zhang, Junyu Wu, Pengde Lu, Lin Xu, Hongchao Yuan, Yibin Feng, Zhe-Sheng Chen, Ning Wang Molecular Cancer.2024;[Epub] CrossRef
Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma Tong-Guo Miao, Shi-Ya Zhang, Yun-Jing Zhang, Dong Ma, Yue-Min Nan Scientific Reports.2024;[Epub] CrossRef
Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma Minami Yamauchi, Masamitsu Maekawa, Toshihiro Sato, Yu Sato, Masaki Kumondai, Mio Tsuruoka, Jun Inoue, Atsushi Masamune, Nariyasu Mano Metabolites.2024; 14(9): 513. CrossRef
Comparison of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma patients: a SEER population-based propensity score matching study Xi Wang, Xinqun Chai, Ruiya Tang, Yunjie Xu, Qinjunjie Chen Updates in Surgery.2024; 76(8): 2755. CrossRef
Multi-stage mechanisms of tumor metastasis and therapeutic strategies Zaoqu Liu, Jingqi Chen, Yuqing Ren, Shutong Liu, Yuhao Ba, Anning Zuo, Peng Luo, Quan Cheng, Hui Xu, Xinwei Han Signal Transduction and Targeted Therapy.2024;[Epub] CrossRef
An Early Increase in IL-10 and TNF-α Levels Following Atezolizumab Plus Bevacizumab Treatment Predicts Survival in Advanced Hepatocellular Carcinoma Patients: A Prospective Cohort Study Soon Kyu Lee, Soon Woo Nam, Ji Won Han, Jung Hyun Kwon Cancers.2024; 16(20): 3543. CrossRef
Prediction of microvascular invasion in hepatocellular carcinoma with conventional ultrasound, Sonazoid-enhanced ultrasound, and biochemical indicator: a multicenter study Dan Lu, Li-Fan Wang, Hong Han, Lin-Lin Li, Wen-Tao Kong, Qian Zhou, Bo-Yang Zhou, Yi-Kang Sun, Hao-Hao Yin, Ming-Rui Zhu, Xin-Yuan Hu, Qing Lu, Han-Sheng Xia, Xi Wang, Chong-Ke Zhao, Jian-Hua Zhou, Hui-Xiong Xu Insights into Imaging.2024;[Epub] CrossRef
Cross-sectional study on the diagnostic significance of plasma exosomal miRNAs in HBV-related hepatocellular carcinoma Xiaoyuan Hu, Fa Huang, Jiyou Yao, Jiaxian Lv, Jialuo Mai, Ning Li, Minqiang Lu Journal of Translational Medicine.2024;[Epub] CrossRef
Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy Teng Zhang, Wengang Li, Qian Chen, Weiping He, Jing Sun, Dong Li, Quan Wang, Xuezhang Duan Frontiers in Immunology.2024;[Epub] CrossRef
Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years Yeshong Park, Ho-Seong Han, Seung Yeon Lim, Hyelim Joo, Jinju Kim, MeeYoung Kang, Boram Lee, Hae Won Lee, Yoo-Seok Yoon, Jai Young Cho Medicina.2024; 61(1): 12. CrossRef
Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study Yi Jiang, Ke Su, Han Li, Chenjie Wang, Zhenying Wu, Jiali Chen, Zhiyao Zhang, Kun He, Yunwei Han Investigational New Drugs.2024;[Epub] CrossRef
What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea? Min Kyung Park, Yoon Jun Kim Clinical and Molecular Hepatology.2023; 29(2): 332. CrossRef
Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan San-Chi Chen Clinical and Molecular Hepatology.2023; 29(2): 352. CrossRef
Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers Shu An, Xiaoxia Zhan, Min Liu, Laisheng Li, Jian Wu Diagnostics.2023; 13(8): 1442. CrossRef
Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma Yanjie Yang, Nan Du, Jingqin Ma, Zhijie Peng, Bo Zhou, Jiaze Yu, Xin Zhou, Wen Zhang, Zhiping Yan Journal of Hepatocellular Carcinoma.2023; Volume 10: 1897. CrossRef
Attenuation of binuclear hepatocytes in the paracancerous liver tissue is associated with short‐term recurrence of hepatocellular carcinoma post‐radical surgery Yifan Zhang, Nan Wang, Fengjie Hao, Yongjun Chen, Xiaochun Fei, Junqing Wang The FASEB Journal.2023;[Epub] CrossRef
Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients Tianying Ren, Xu Hou, Xin Zhang, Dongliang Chen, Juan Li, Yingnan Zhu, Zhiheng Liu, Dawei Yang Heliyon.2023; 9(11): e21906. CrossRef
Protein induced by vitamin K absence or antagonist II: Experience to date and future directions Libin Dong, Xun Qiu, Fengqiang Gao, Kai Wang, Xiao Xu Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2023; 1878(6): 189016. CrossRef
Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area Joo Hyun Oh, Jonghyun Lee, Eileen L. Yoon, Soung Won Jeong, Soon Sun Kim, Young Eun Chon, Sang Bong Ahn, Dae Won Jun Cancers.2023; 16(1): 150. CrossRef
First
Prev
